PEPLIN PHARMACEUTICALS FOR LIFE Trademark

Trademark Overview


On Thursday, September 16, 2004, a trademark application was filed for PEPLIN PHARMACEUTICALS FOR LIFE with the United States Patent and Trademark Office. The USPTO has given the PEPLIN PHARMACEUTICALS FOR LIFE trademark a serial number of 78484582. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 6, 2013. This trademark is owned by Peplin Biotech Ltd. The PEPLIN PHARMACEUTICALS FOR LIFE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Vaccines, pharmaceuticals, medical preparations, diagnostic preparations and therapeutic agents for the treatment, prevention and diagnosis of diabetes, dermatological, respiratory and/or inflammatory conditions, namely, acne, angina, arthritis, aspiration pneumonia, emphysema, gastroenteritis, intestinal flu, necrotizing enterocolitis, pelvic inflammatory disease, pharyngitis, PID, pleurisy, raw throat, redness, rubor, sore throat, stomach flu and urinary tract infections, chronic inflammatory demyelinating polyneuropathy, chronic inflammatory demyelinating polyradiculoneuropathy; Vaccines, pharmaceuticals, medical preparations, diagnostic preparations and therapeutic agents for the treatment of cancers, namely, tumors, sarcomas, carcinomas and melanomas including tumors of the colon, breast, neck, throat, bladder, brain, liver, pancreas, adrenal glands, lymph, testicles, uterus, ovaries, lung as well solid and blood borne tumors such as ABL1 protooncogene, AIDS related cancers, acous...

Research and development, in relation to medical, biological and/or chemical diagnostic preparations, namely the identification evaluation and development of pharmaceuticals, pharmaceuticals for the treatment, prevention and diagnosis of diabetes, dermatological, respiratory and/or inflammatory conditions, namely, acne, angina, arthritis, aspiration pneumonia, emphysema, gastroenteritis, intestinal flu, necrotizing enterocolitis, pelvic inflammatory disease, pharyngitis, PID, pleurisy, raw throat, redness, rubor, sore throat, stomach flu and urinary tract infections, chronic inflammatory demyelinating polyneuropathy, chronic inflammatory demyelinating polyradiculoneuropathy; Research and development in relation to cancers including tumors, sarcomas, carcinomas and melanomas including tumors of the colon, breast, neck, throat, bladder, brain, liver, pancreas, adrenal glands, lymph, testicles, uterus, ovaries, lung as well solid and blood borne tumors such as ABL1 protooncogene, AIDS rel...
peplin pharmaceuticals for life

General Information


Serial Number78484582
Word MarkPEPLIN PHARMACEUTICALS FOR LIFE
Filing DateThursday, September 16, 2004
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 6, 2013
Registration Number3235825
Registration DateTuesday, May 1, 2007
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 13, 2007

Trademark Statements


Amendment to a Registration/Renewal CertificateIn the statement, Column 2, lines 3 through 12 " democratic carcinoma, democratically cancer, antigenic myeloid metals, alpace, anglo-saxon, plastic anemia, abstractional, ataxia-eaglets, brain stem glom, brain and cans tumors, cans tumors" should be deleted, and adenocystic carcinoma, adrenocortical cancer, agnogenic myeloid metaplasia, alopecia, angio-sarcoma, aplastic anemia, astrocytoma, ataxia-telangiectasia, brain stem glioma, brain and CNS tumors should be inserted.
Disclaimer with Predetermined Text"pharmaceuticals"
Description of MarkThe mark consists of Word and propeller-type design.
Goods and ServicesVaccines, pharmaceuticals, medical preparations, diagnostic preparations and therapeutic agents for the treatment, prevention and diagnosis of diabetes, dermatological, respiratory and/or inflammatory conditions, namely, acne, angina, arthritis, aspiration pneumonia, emphysema, gastroenteritis, intestinal flu, necrotizing enterocolitis, pelvic inflammatory disease, pharyngitis, PID, pleurisy, raw throat, redness, rubor, sore throat, stomach flu and urinary tract infections, chronic inflammatory demyelinating polyneuropathy, chronic inflammatory demyelinating polyradiculoneuropathy; Vaccines, pharmaceuticals, medical preparations, diagnostic preparations and therapeutic agents for the treatment of cancers, namely, tumors, sarcomas, carcinomas and melanomas including tumors of the colon, breast, neck, throat, bladder, brain, liver, pancreas, adrenal glands, lymph, testicles, uterus, ovaries, lung as well solid and blood borne tumors such as ABL1 protooncogene, AIDS related cancers, acoustic neuroma, acute lymphocyte leukemia, acute myeloid leukemia,adenocystic carcinoma, adrenocrtical cancer, agnogenic myeloid metaplasia, alopecia, alveolar soft-part sarcoma, anal cancer, angio-sarcoma, aplastic anemia, astrocytoma, ataxia-telangiectasia, basal cell carcinoma, bladder cancer, bone cancers, bowel cancer, brain stem glioma, brain and CNS tumors, breast cancer, CNS tumors, carcinoid tumors, cervical cancer, childhood brain tumors, childhood cancer, childhood leukemia, childhood soft tissue sarcoma, chondrosarcoma, choriocarcinoma, chronic lymphocytic leukemia, chronic myeloid leukemia, colorectal cancers, cutaneous T-cell lymphoma, dermatofibrosarcoma-protuberans, desmoplastic-small-round-cell-tumor, ductal carcinoma, endocrine cancers, endometrial cancer, ependymoma, esophageal cancer, Ewing's sarcoma, extra-hepatic bile duct cancer, eye cancer, fallopian tube cancer, fanconi anemia, fibrosarcoma, gall bladder cancer, gastric cancer, gastrointestinal cancers, gastrointestinal-carcinoid-tumor, genitourinary cancers, germ cell tumors, gestational-trophoblastic-disease, glioma, gynecological cancers, hematological malignancies, hairy cell leukemia, head and neck cancer, hepatocellular cancer, hereditary breast cancer, histiocytosis, Hodgkin's disease, human papillomavirus, hydatidiform mole, hypercalcemia, hypopharynx cancer, intraocular melanoma, islet cell cancer, Kaposi's sarcoma, kidney cancer, Langerhan's-cell-histiocytosis, laryngeal cancer, leiomyosarcoma, leukemia, Li-Fraumeni syndrome, lip cancer, liposarcoma, liver cancer, lung cancer, lymphedema, lymphoma, Hodgkin's lymphoma, non-Hodgkin's lymphoma, male breast cancer, malignant-rhabdoid-tumor-of-kidney, medulloblastoma, melanoma, Merkel cell cancer, mesothelioma, metastatic cancer, mouth cancer, multiple endocrine neoplasia, mycosis fungoides, myelodysplastic syndromes, myeloma, myeloproliferative disorders, nasal cancer, nasopharyngeal cancer, nephroblastoma, neuroblastoma, neurofibromatosis, Nijmegen breakage syndrome, non-melanoma skin cancer, non-small-cell-lung-cancer, ocular cancers, oesophageal cancer, oral cavity cancer, oropharynx cancer, osteosarcoma, ostomy ovarian cancer, pancreas cancer, paranasal cancer, parathyroid cancer, parotid gland cancer, penile cancer, peripheral-neuroectodermal-tumors, pituitary cancer, polycythemia vera, prostate cancer, rare-cancers-and-associated-disorders, renal cell carcinoma, retinoblastoma, rhabdomyosarcoma, Rothmund-Thomson syndrome, salivary gland cancer, schwannoma, Sezary syndrome, skin cancer, small cell lung cancer, small intestine cancer, soft tissue sarcoma, spinal cord tumors, squamous cell carcinoma, stomach cancer, synovial sarcoma, testicular cancer, thymus cancer, thyroid cancer, transitional-cell-cancer of the bladder, transitional-cell-cancer of the renal, pelvis and ureter, trophoblastic cancer, urethral cancer, urinary system cancer, uroplakins, uterine sarcoma, uterus cancer, vaginal cancer, vulva cancer, Waldenstrom's-macroglobulinemia and Wilms' tumor
Goods and ServicesResearch and development, in relation to medical, biological and/or chemical diagnostic preparations, namely the identification evaluation and development of pharmaceuticals, pharmaceuticals for the treatment, prevention and diagnosis of diabetes, dermatological, respiratory and/or inflammatory conditions, namely, acne, angina, arthritis, aspiration pneumonia, emphysema, gastroenteritis, intestinal flu, necrotizing enterocolitis, pelvic inflammatory disease, pharyngitis, PID, pleurisy, raw throat, redness, rubor, sore throat, stomach flu and urinary tract infections, chronic inflammatory demyelinating polyneuropathy, chronic inflammatory demyelinating polyradiculoneuropathy; Research and development in relation to cancers including tumors, sarcomas, carcinomas and melanomas including tumors of the colon, breast, neck, throat, bladder, brain, liver, pancreas, adrenal glands, lymph, testicles, uterus, ovaries, lung as well solid and blood borne tumors such as ABL1 protooncogene, AIDS related cancers, acoustic neuroma, acute lymphocytic leukemia, acute myeloid leukemia, adenocystic carcinoma, adrenocortical cancer, agnogenic myeloid metaplasia, alopecia, alveolar soft-part sarcoma, anal cancer, angiosarcoma, aplastic anemia, astrocytoma, ataxia-telangiectasia, basal cell carcinoma, bladder cancer, bone cancers, bowel cancer, brain stem glioma, brain and CNS tumors, breast cancer, CNS tumors, carcinoid tumors, cervical cancer, childhood brain tumors, childhood cancer, childhood leukemia, childhood soft tissue sarcoma, chondrosarcoma, choriocarcinoma, chronic lymphocytic leukemia, chronic myeloid leukemia, colorectal cancers, cutaneous T-cell lymphoma, dermatofibrosarcoma-protuberans, desmoplastic-small-round-cell-tumor, ductal carcinoma, endocrine cancers, endometrial cancer, ependymoma, esophageal cancer, Ewing's sarcoma, extra-hepatic bile duct cancer, eye cancer, fallopian tube cancer, fanconi anemia, fibrosarcoma, gall bladder cancer, gastric cancer, gastrointestinal cancers, gastrointestinal-carcinoid-tumor, genitourinary cancers, germ cell tumors, gestational-trophoblastic-disease, glioma, gynecological cancers, hematological malignancies, hairy cell leukemia, head and neck cancer, hepatocellular cancer, hereditary breast cancer, histiocytosis, Hodgkin's disease, human papillomavirus, hydatidiform mole, hypercalcemia, hypopharynx cancer, intraocular melanoma, islet cell cancer, Kaposi's sarcoma, kidney cancer, Langerhan's-cell-histiocytosis, laryngeal cancer, leiomyosarcoma, leukemia, Li-Fraumeni syndrome, lip cancer, liposarcoma, liver cancer, lung cancer, lymphedema, lymphoma, Hodgkin's lymphoma, non-Hodgkin's lymphoma, male breast cancer, malignant-rhabdoid-tumor-of-kidney, medulloblastoma, melanoma, Merkel cell cancer, mesothelioma, metastatic cancer, mouth cancer, multiple endocrine neoplasia, mycosis fungoides, myelodysplastic syndromes, myeloma, myeloproliferative disorders, nasal cancer, nasopharyngeal cancer, nephroblastoma, neuroblastoma, neurofibromatosis, Nijmegen breakage syndrome, non-melanoma skin cancer, non-small-cell-lung-cancer, ocular cancers, oesophageal cancer, oral cavity cancer, oropharynx cancer, osteosarcoma, ostomy ovarian cancer, pancreas cancer, paranasal cancer, parathyroid cancer, parotid gland cancer, penile cancer, peripheral-neuroectodermal-tumors, pituitary cancer, polycythemia vera, prostate cancer, rare-cancers-and-associated-disorders, renal cell carcinoma, retinoblastoma, rhabdomyosarcoma, Rothmund-Thomson syndrome, salivary gland cancer, schwannoma, Sezary syndrome, skin cancer, small cell lung cancer, small intestine cancer, soft tissue sarcoma, spinal cord tumors, squamous cell carcinoma, stomach cancer, synovial sarcoma, testicular cancer, thymus cancer, thyroid cancer, transitional-cell-cancer of the bladder, transitional-cell-cancer of the renal, pelvis, ureter, trophoblastic cancer, urethral cancer, urinary system cancer, uroplakins, uterine sarcoma, uterus cancer, vaginal cancer, vulva cancer, Waldenstrom's-macroglobulinemia and Wilms' tumor

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 6, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 6, 2013
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePEPLIN LIMITED
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNEWSTEAD, QUEENSLAND 4006
AU

Party NamePEPLIN LIMITED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNEWSTEAD, QUEENSLAND 4006
AU

Party NamePEPLIN LIMITED
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressNEWSTEAD, QUEENSLAND 4006
AU

Party NamePeplin Biotech Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewstead, Queensland 4006
AU

Trademark Events


Event DateEvent Description
Friday, December 6, 2013CANCELLED SEC. 8 (6-YR)
Thursday, September 5, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 1, 2007AMENDMENT UNDER SECTION 7 ¿ PROCESSED
Thursday, July 12, 2007ASSIGNED TO PARALEGAL
Thursday, June 7, 2007SEC 7 REQUEST FILED
Thursday, June 7, 2007PAPER RECEIVED
Tuesday, May 1, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, February 13, 2007PUBLISHED FOR OPPOSITION
Wednesday, January 24, 2007NOTICE OF PUBLICATION
Friday, December 15, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, December 14, 2006ASSIGNED TO LIE
Wednesday, November 29, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 8, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, November 2, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 2, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 5, 2006NON-FINAL ACTION MAILED
Friday, May 5, 2006NON-FINAL ACTION WRITTEN
Thursday, April 6, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 31, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 5, 2006AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, March 31, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 10, 2006AMENDMENT FROM APPLICANT ENTERED
Friday, January 27, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 27, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, November 23, 2005LETTER OF SUSPENSION MAILED
Wednesday, November 23, 2005SUSPENSION LETTER WRITTEN
Tuesday, November 1, 2005TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 26, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 26, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 27, 2005NON-FINAL ACTION MAILED
Wednesday, April 27, 2005NON-FINAL ACTION WRITTEN
Sunday, April 17, 2005ASSIGNED TO EXAMINER
Wednesday, September 22, 2004NEW APPLICATION ENTERED IN TRAM